MYD88 and diffuse large B-cell lymphoma: Lymphomas with such mutations include the activated B-cell (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) (98, 99, 103, 105, 106), in which chronic active BCR signaling is often combined with oncogenic activation of the TLR signaling component MyD88 (107).